Replies to post #24190 on Relief Therapeutics Holding AG (RLFTF)

[smm886]

12:50 is where they talk about interim data

[nelskof]

It's 102 patients. "INTERIM" review in 28 days and 4 things can happen then.

1. Stop trial due to safety issues
2. Stop trial due to lack of efficacy
3. Continue trial (144 patients) DMC believes they can reach end points
4. Stop trial because efficacy has been demonstrated, it would be unethical to continue with placebo

All of us, including Dr Javitt, are rooting for #4. We were rooting for it end of August/beginning of September. I didn't think I would be rooting for it again, lol. At the end of today's video JJ showed excitement discussing this.